Edition:
United Kingdom

Genmab A/S (GEN.CO)

GEN.CO on Copenhagen Stock Exchange

1,032.00DKK
15 Dec 2017
Change (% chg)

kr.-2.00 (-0.19%)
Prev Close
kr.1,034.00
Open
kr.1,034.00
Day's High
kr.1,059.00
Day's Low
kr.1,021.00
Volume
457,960
Avg. Vol
289,282
52-wk High
kr.1,489.00
52-wk Low
kr.1,015.00

Select another date:

Tue, Dec 12 2017

BRIEF-Biotech Genmab sees 2018 expense growth of 40-50 pct

Dec 12 FOLLOWING ARE STATEMENTS FROM GENMAB'S R'N'D UPDATE IN ATLANTA, GEORGIA:

Genmab and Johnson & Johnson 'love' partnership as some ponder takeover

LONDON Genmab was Europe's second biggest biotech company, until its partner Johnson & Johnson bought Switzerland's Actelion for $30 billion this year and propelled the Danish antibody specialist to the top spot.

Genmab and J&J 'love' partnership as some ponder takeover

LONDON Genmab was Europe's second biggest biotech company, until its partner Johnson & Johnson bought Switzerland's Actelion for $30 billion (£22.30 billion) this year and propelled the Danish antibody specialist to the top spot.

Europe's top biotech expects delays from drugs watchdog's HQ move

LONDON Europe's biggest biotechnology company, Denmark's Genmab, expects some delays to regional drug approvals as the European Medicines Agency is uprooted from London to Amsterdam.

Europe's top biotech expects delays from drugs watchdog's HQ move

LONDON Europe's biggest biotechnology company, Denmark's Genmab, expects some delays to regional drug approvals as the European Medicines Agency is uprooted from London to Amsterdam.

Europe's top biotech expects delays from drugs watchdog's HQ move

LONDON, Nov 30 Europe's biggest biotechnology company, Denmark's Genmab, expects some delays to regional drug approvals as the European Medicines Agency is uprooted from London to Amsterdam.

BRIEF-Genmab Achieves $20 Million Milestone In Daratumumab Collaboration With Janssen

* GENMAB ACHIEVES USD 20 MILLION MILESTONE IN DARATUMUMAB COLLABORATION WITH JANSSEN AND UPDATES FINANCIAL GUIDANCE

BRIEF-Genmab gets USD 3 million in milestone payments from Janssen

* ‍GENMAB TO RECEIVE USD 3 MILLION IN MILESTONE PAYMENTS FROM JANSSEN​

BRIEF-Genmab: $50 mln milestone payment in collaboration on Darzalex

* SAID ON FRIDAY WILL RECEIVE MILESTONE PAYMENT OF USD 50 MILLION IN DARZALEX COLLABORATION WITH JANSSEN BIOTECH, INC.

BRIEF-Genmab Q3 net loss DKK 5.7 mln, misses estimates

* GENMAB ANNOUNCES FINANCIAL RESULTS FOR THE FIRST NINE MONTHS OF 2017

Select another date: